UroGen Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.About URGN
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.
CEOElizabeth Barrett, MBA
CEOElizabeth Barrett, MBA
Employees235
Employees235
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2004
Founded2004
Employees235
Employees235
URGN Key Statistics
Market cap1.35B
Market cap1.35B
Price-Earnings ratio-8.32
Price-Earnings ratio-8.32
Dividend yield—
Dividend yield—
Average volume1.10M
Average volume1.10M
High today$29.46
High today$29.46
Low today$28.42
Low today$28.42
Open price$29.40
Open price$29.40
Volume378.73K
Volume378.73K
52 Week high$30.00
52 Week high$30.00
52 Week low$3.42
52 Week low$3.42
Stock Snapshot
The current UroGen Pharma(URGN) stock price is $28.81, with a market capitalization of 1.35B. The stock trades at a price-to-earnings (P/E) ratio of -8.32.
On 2025-11-29, UroGen Pharma(URGN) stock moved within a range of $28.42 to $29.46. With shares now at $28.81, the stock is trading +1.4% above its intraday low and -2.2% below the session's peak.
Trading activity shows a volume of 378.73K, compared to an average daily volume of 1.1M.
The stock's 52-week range extends from a low of $3.42 to a high of $30.00.
The stock's 52-week range extends from a low of $3.42 to a high of $30.00.
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own URGN. This list is generated using Robinhood data, and it’s not a recommendation.